swatic's blog

Report Overview:

The Global Reprocessed Medical Devices Market achieved a valuation of $2.29 Billion in 2022 and is anticipated to exceed $6.72 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 14.4% during the forecast period from 2024 to 2032.

Key Market Players:

GE Healthcare, Medline Industries, Renu Medical (Arjo), Soma Technology, Stryker, Teleflex Incorporated, Medtronic, Innovative Health, Vanguard AG, Ethicon, and SureTek Medical.

Report Overview:

The Global Tele Intensive Care Unit Market achieved a valuation of $3.48 Billion in 2022 and is anticipated to exceed $11.43 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 16% during the forecast period from 2024 to 2032.

Key Market Players:

Inova (US), INTeLeICU (India), InTouch Technologies Inc. (US), Koninklijke Philips NV (Netherlands), Advanced ICU Care (US).

Report Overview:

The Global Clinical Communication and Collaboration Market achieved a valuation of $2.34 Billion in 2022 and is anticipated to exceed $8.32 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 17.2% during the forecast period from 2024 to 2032.

Key Market Players:

Spok Inc.; Cerner Corporation; Hill Room Services, Inc.; Vocera Communications; and Cisco Systems Inc.

Report Overview:

The Global ICU Beds Market achieved a valuation of $1672.65 Million in 2022 and is anticipated to exceed $2471.28 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 5% during the forecast period from 2024 to 2032.

Key Market Players:

DSV Panalpina A/S (Span-America Medical Systems, Inc.), Hill-Rom Holdings Inc., Getinge AB, Joh. Stiegelmeyer & Co. GmbH (Stiegelmeyer GmbH & Co. KG), Invacare Corporation, Malvestio S.P.A., Linet Group SE (Linet spol. s.r.o.), Merivaara Corp., Medline Industries Inc., Stryker Corporation

Report Overview:

The Global Platelet Aggregation Devices Market achieved a valuation of $532.56 Million in 2022 and is anticipated to exceed $868.23 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 6.3% during the forecast period from 2024 to 2032.

Key Market Players:

Bio/Data Corporation (US), Helena Laboratories Corporation (US), WerfenLife (Spain),F.Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany).

Report Overview:

The Global Autologous Cell Therapy Product Market achieved a valuation of $11.69 Billion in 2022 and is anticipated to exceed $40.77 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 16.9% during the forecast period from 2024 to 2032.

Key Market Players:

Vericel Corporation (US), Pharmicell Co. Inc(South Korea), Holostem Terapie Avanzate S.R.L (Italy), Lineage Cell Therapeutics Inc. (US), Opexa Therapeutics (US)

Report Overview:

The Global Single Cell Analysis Market achieved a valuation of $2.30 Billion in 2022 and is anticipated to exceed $6.99 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 14.9% during the forecast period from 2024 to 2032.

Key Market Players:

Bio-Rad Laboratories Inc. (US), Illumina Inc. (US), Beckman Coulter Inc. (US), Danaher Corporation (US), Becton (US), Dickinson and Company (US), Fluidigm Corporation (US).

Report Overview:

The Global Digital Health Market achieved a valuation of $169.36 Billion in 2022 and is anticipated to exceed $586.59 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 16.8% during the forecast period from 2024 to 2032.

Key Market Players:

Allscripts Healthcare Solutions Inc. (US), Cisco Systems (US), Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), and Cerner Corporation (US) and others.

Report Overview:

The Global Compound Management Market achieved a valuation of $412.51 Million in 2022 and is anticipated to exceed $1371.17 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 16.2% during the forecast period from 2024 to 2032.

Key Market Players:

Brooks Life Sciences (US), Titian Software Limited (UK), Beckman Coulter Inc (US), Hamilton Company (US) , Evotec (Germany).

Report Overview:

The Global Medical Transcription Market achieved a valuation of $1.17 Billion in 2022 and is anticipated to exceed $4.06 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 16.8% during the forecast period from 2024 to 2032.

Key Market Players:

Acusis LLC (US), Transcend Services (Taiwan), Nuance Communications Inc. (US), MModal LLC (US), iMedX Inc. (US), Global Medical Transcription LLC (US), nThrive Inc. (US), MTBC Inc. (US), Medi-Script Plus (US), TransTech Medical Solutions LLC (US), etc.